427 results on '"Mason, Jay W."'
Search Results
2. Myocarditis
3. Immunoglobulin Free Light Chains as Inflammatory Biomarkers of Atrial Fibrillation
4. Salutary Effects of the PULVAD, a Novel Implantable Counterpulsation Assist Device, on Cardiac Mechanoenergetics
5. New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits
6. EDITORIAL COMMENTARY: The Methadone Menace
7. Myocarditis
8. Gene-Based Therapy of Long QT Syndrome
9. Inflammation and myocarditis
10. Treatment of Lymphocytic Myocarditis
11. Autoantibodies against cardiac troponin I in patients presenting with myocarditis
12. Inflammatory Heart Disease
13. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development
14. Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study
15. Surface Electrocardiographic Parameters of Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder in an Ambulatory Community Pediatric Center: A Focus on Cardiac Repolarization Electrocardiogram Intervals
16. Immunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis
17. Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part II: Electrocardiography Diagnostic Statement List A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology
18. Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
19. Myocarditis
20. Myocarditis and Heart Failure Associated With Hepatitis C Virus Infection
21. Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active-Controlled Cardiac Repolarization Studies
22. Oritavancin, a New Lipoglycopeptide Antibiotic: Results From a Thorough QT Study
23. Clinical significance of syncope in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial
24. Automated QT Analysis That Learns from Cardiologist Annotations
25. A clinical trial of immunosuppressive therapy for myocarditis
26. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias
27. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias
28. A new oral therapy for long QT syndrome: Long-term oral potassium improves repolarization in patients with HERGmutations
29. Dilated Cardiomyopathy*: Problems in Diagnosis and Management
30. Salutary Effects of the PULVAD, a Novel Implantable Counterpulsation Assist Device, on Cardiac Mechanoenergetics
31. Correction of the QRS duration for heart rate
32. Comparison of Electrocardiographic Biomarkers for Differentiating Drug‐Induced Single vs. Multiple Cardiac Ion Channel Block
33. Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study
34. Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone
35. Do Patients Prefer Physiologic Pacing?
36. Arrhythmias Associated with Myocarditis
37. Inflammatory myocardial diseases and cardiomyopathies
38. Immunosuppressive Therapy for Myocarditis
39. The Treatment Of Ventricular Tachyarrhythmias
40. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography : A report of the ACC/AHA/ACP–ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography) Endorsed by the International Society for Holter and Noninvasive Electrocardiology
41. Predicting antiarrhythmic drug efficacy
42. Evaluation of the Cardiac Safety of Long‐Acting Endectocide Moxidectin in a Randomized Concentration‐QT Study
43. Correction: Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block
44. 199 Cardiac Safety and QTc Intervals With DM/Q Treatment for Pseudobulbar Affect: A Review of Clinical Trial Data
45. Comparison of Two Highly Automated ECG Algorithms for Detection of Drug-Induced Cardiac Ion Channel Block
46. Cardiologist's point of view: Novel ECG biomarkers and in silico models for proarrhythmic risk prediction: Are we ready?
47. Debatable issues in automated ECG reporting
48. Is there an ideal ventricular stimulation protocol?
49. A Look to the Future: Outpatient Placebo Controlled Trials of Antiarrhythmic Drug Efficacy in Patients with Life Threatening Ventricular Arrhythmias
50. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.